Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cryoprobe Versus Forceps for Transbronchial Biopsy

NCT: NCT05751278 · COMPLETED

NCT IDNCT05751278
StatusCOMPLETED
Start Date2023-02-27
Completion2026-03-02

Brief Summary

The purpose of this study is to compare the effectiveness of transbronchial biopsy done by a 1.1mm cryoprobe versus the standard 2.0mm forceps.

Frequently Asked Questions

What is Cryoprobe Versus Forceps for Transbronchial Biopsy?

Cryoprobe Versus Forceps for Transbronchial Biopsy is a clinical trial registered under NCT05751278. Current status: COMPLETED.

What is the status of NCT05751278?

The current status of NCT05751278 (Cryoprobe Versus Forceps for Transbronchial Biopsy) is: COMPLETED.

When did Cryoprobe Versus Forceps for Transbronchial Biopsy start?

Cryoprobe Versus Forceps for Transbronchial Biopsy started on 2023-02-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑